XXX - Fluconazole vs Fluconazole + Lacticaseibacillus rhamnosus GR-1 + Limosilactobacillus reuteri RC-14 & Vulvovaginal candidiasis (VVC) / Vaginal yeast infection

Study overview

It is a randomized, double-blind and placebo-controlled trial studying Fluconazole (150 mg) supplemented every morning for the following 4 weeks or Fluconazole + Lacticaseibacillus rhamnosus GR-1 + Limosilactobacillus reuteri RC-14 in 55 women with Vulvovaginal candidiasis (VVC) / Vaginal yeast infection (1)

Outcome measures

Vaginal discharge positive for Candida spp. (according to culture method) associated with at least one of the symptoms (itching and burning vaginal feeling, dyspareunia and dysuria) (1)

Results

After four weeks, the group treated with p…